In contrast, the lncRNA NBR2 acts as a tumor inhibitor in HCC, suppressing Beclin1 and autophagy via ERK/JNK pathways to limit HCC cell proliferation (Sheng et al., 2021). Here, NBR2 is linked to hepatocellular carcinoma.